Insider Trading disclosures for Milestone Pharmaceuticals Inc

The latest disclosure was made by Jeffrey Edward Nelson in Milestone Pharmaceuticals Inc where a trade of 80,400 Restricted Stock Unit done was reported to US exchanges on Jan. 27, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Jeffrey Edward Nelson	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	80,400	80,400	-		-	Restricted Stock Unit
Jeffrey Edward Nelson	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	120,600	120,600	-		-	Employee Stock Option (right to buy)
David Bharucha	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	120,600	120,600	-		-	Employee Stock Option (right to buy)
David Bharucha	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	80,400	80,400	-		-	Restricted Stock Unit
Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	80,400	80,400	-		-	Restricted Stock Unit
Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	120,600	120,600	-		-	Employee Stock Option (right to buy)
Lorenz Muller	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	120,600	120,600	-		-	Employee Stock Option (right to buy)
Lorenz Muller	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	80,400	80,400	-		-	Restricted Stock Unit
Joseph G. Oliveto	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	266,400	266,400	-		-	Restricted Stock Unit
Joseph G. Oliveto	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2025	399,600	399,600	-		-	Employee Stock Option (right to buy)
Joseph C. Papa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Sep 2024	80,000	80,000	-		-	Stock Option (right to buy)
Lisa M. Giles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2024	40,000	40,000	-		-	Stock Option (right to buy)
Michael J. Tomsicek	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2024	40,000	40,000	-		-	Stock Option (right to buy)
Seth H.Z. Fischer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2024	40,000	40,000	-		-	Stock Option (right to buy)
Robert J. Wills	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2024	40,000	40,000	-		-	Stock Option (right to buy)
Stuart M. Duty	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2024	40,000	40,000	-		-	Stock Option (right to buy)
Andrew Saik	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2024	40,000	40,000	-		-	Stock Option (right to buy)
Stuart M. Duty	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2024	80,000	80,000	-		-	Stock Option (right to buy)
Andrew Saik	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2024	80,000	80,000	-		-	Stock Option (right to buy)
Robert J. Wills	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2023	30,000	30,000	-		-	Stock Option (right to buy)
Debra K. Liebert	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2023	30,000	30,000	-		-	Stock Option (right to buy)
Richard C. Pasternak	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2023	30,000	30,000	-		-	Stock Option (right to buy)
Seth H.Z. Fischer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Mar 2023	42,000	42,000	-		-	Stock Option (right to buy)
Joseph G. Oliveto	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2023	360,000	360,000	-		-	Employee Stock Option (right to buy)
Lorenz Muller	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2023	105,000	105,000	-		-	Employee Stock Option (right to buy)
Amit Hasija	CFO & EVP of Corp. Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2023	130,000	130,000	-		-	Employee Stock Option (right to buy)
David Bharucha	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2023	185,000	185,000	-		-	Employee Stock Option (right to buy)
Jeffrey Edward Nelson	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2023	105,000	105,000	-		-	Employee Stock Option (right to buy)
David Bharucha	Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 4.86 per share.	01 Dec 2022	3,000	3,000 (0%)	0%	4.9	14,580	Common Shares
David Bharucha	Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 4.69 per share.	01 Dec 2022	7,000	10,000 (0%)	0%	4.7	32,830	Common Shares
Richard C. Pasternak	Director	Purchase of securities on an exchange or from another person at price $ 5.20 per share.	20 Oct 2022	10,000	10,000 (0%)	0%	5.2	52,000	Common Shares
Debra K. Liebert	Director	Purchase of securities on an exchange or from another person at price $ 5.29 per share.	20 Oct 2022	10,000	10,000 (0%)	0%	5.3	52,900	Common Shares
Debra K. Liebert	Director	Purchase of securities on an exchange or from another person at price $ 5.26 per share.	20 Oct 2022	4,000	4,000 (0%)	0%	5.3	21,040	Common Shares
Michael J. Tomsicek	Director	Purchase of securities on an exchange or from another person at price $ 5.32 per share.	19 Oct 2022	15,000	15,000 (0%)	0%	5.3	79,800	Common Shares
Robert J. Wills	Director	Purchase of securities on an exchange or from another person at price $ 4.93 per share.	19 Oct 2022	15,000	15,000 (0%)	0%	4.9	73,950	Common Shares
Debra K. Liebert	Director	Other type of transaction at price $ 0.00 per share.	14 Sep 2022	127	127 (0%)	0%		0	Common Shares
Debra K. Liebert	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jul 2022	30,000	30,000	-		-	Stock Option (right to buy)
Robert J. Wills	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jul 2022	30,000	30,000	-		-	Stock Option (right to buy)
Michael J. Tomsicek	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jul 2022	30,000	30,000	-		-	Stock Option (right to buy)
Lisa M. Giles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jul 2022	30,000	30,000	-		-	Stock Option (right to buy)
Richard C. Pasternak	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jul 2022	30,000	30,000	-		-	Stock Option (right to buy)
Paul F. Truex	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.66 per share.	31 May 2022	822	76,780 (0%)	0%	2.7	2,187	Common Shares
Paul F. Truex	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 May 2022	45,072	0	-		-	Stock Option (right to buy)
Paul F. Truex	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 May 2022	22,870	2,659	-		-	Stock Option (right to buy)
Paul F. Truex	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 May 2022	822	117	-		-	Stock Option (right to buy)
Paul F. Truex	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.54 per share.	31 May 2022	22,870	75,958 (0%)	0%	1.5	35,220	Common Shares
Paul F. Truex	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.54 per share.	31 May 2022	45,072	53,088 (0%)	0%	1.5	69,411	Common Shares
Paul F. Truex	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share.	31 May 2022	8,016	8,016 (0%)	0%	1.1	8,978	Common Shares
Paul F. Truex	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 May 2022	8,016	0	-		-	Stock Option (right to buy)
Paul F. Truex	Director	Purchase of securities on an exchange or from another person at price $ 5.60 per share.	31 May 2022	5,000	81,780 (0%)	0%	5.6	28,000	Common Shares

Showing 1 to 50 of 97 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

74.11% Gain from 52W Low

Insider Trading disclosures for Milestone Pharmaceuticals Inc

The latest disclosure was made by Jeffrey Edward Nelson in Milestone Pharmaceuticals Inc where a trade of 80,400 Restricted Stock Unit done was reported to US exchanges on Jan. 27, 2025.

Screeners based on Insider Trading and SAST parameters